Dr. Reddy’s sets FY26 results date and earnings call

Dr. Reddy’s Laboratories filed a Form 6-K to notify investors that it will release its Q4 and full-year FY26 results for the period ended March 31, 2026 on Tuesday, May 12, 2026, after a Board meeting.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

6-K

Rhea-AI Filing Summary

Dr. Reddy’s Laboratories filed a Form 6-K to notify investors that it will release its Q4 and full-year FY26 results for the period ended March 31, 2026 on Tuesday, May 12, 2026, after a Board meeting.

The company will distribute the financial results through stock exchanges, media, its website, and email, and will host an earnings call on May 12, 2026 at 19:30 IST / 10:00 ET. An audio recording and transcript of the call, as well as a press meet presentation, will be made available on its website.

Key Terms

foreign private issuer, financial results, earnings call, transcript of the Earnings call

4 terms

foreign private issuer regulatory

"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

financial results financial

"Release of financial results | Tuesday, May 12th, 2026, after the Board Meeting"

earnings call financial

"Earnings call slated @19:30 PM IST / 10:00 AM ET"

A scheduled public meeting—usually by phone or webcast—where a company’s executives present recent financial results and answer questions from analysts and investors. It matters because listeners hear both the factual “report card” on past performance and the leaders’ tone and outlook for the future; new details or shifts in confidence can change investor expectations and move the stock price, much like a parent-teacher meeting revealing a student’s progress and plans.

transcript of the Earnings call financial

"Audio as well as Transcript of the Earnings call | Will be available on the Company’s Website"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Dr. Reddy’s (RDY) release its Q4 and full-year FY26 results?

Dr. Reddy’s will release its Q4 and full-year FY26 financial results on Tuesday, May 12, 2026, after its Board Meeting. The results will be shared via stock exchanges, media, company website, and email for broad investor access.

What time is Dr. Reddy’s (RDY) FY26 earnings call scheduled?

The FY26 earnings call is scheduled for Tuesday, May 12, 2026 at 19:30 PM IST / 10:00 AM ET. Company management will discuss financial performance, and both audio and transcript will later be available on Dr. Reddy’s website.

How can investors access Dr. Reddy’s Q4 FY26 financial results?

Investors can access Dr. Reddy’s Q4 and full-year FY26 results through stock exchange filings, media announcements, the company’s website, and email. A press meet presentation will also be posted on the website for additional context on the performance.

Will a replay or transcript of Dr. Reddy’s FY26 earnings call be available?

Yes. Dr. Reddy’s plans to make both the audio and written transcript of its FY26 earnings call available on the company’s website. This allows investors who cannot join live to review the management discussion later.

Where can I find details and materials for Dr. Reddy’s FY26 earnings call?

Details for the FY26 earnings call, including timing and access, are provided in the company’s notice. The call is hosted by Dr. Reddy’s, and related materials, audio, and transcript will be made available on www.drreddys.com after the event.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/24/2026 - 07:06 AM EDT

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

April, 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______

Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ¨ No x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits

99.1		Intimation dated April 24, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED (Registrant)

Date: April 24, 2026	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

Exhibit 99.1

Dr. Reddy's Laboratories Ltd.

8-2-337, Road No. 3, Banjara Hills

Hyderabad – 500 034, Telangana, India

CIN: L85195TG1984PLC004507

Tel: + 91 40 4900 2900

Fax: + 91 40 4900 2999

Email: mail@drreddys.com

Web: www.drreddys.com

April 24, 2026

National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)

BSE Limited (Stock Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/ Madam,

Sub: Intimation of Earnings call

Please find enclosed a notification titled “Dr. Reddy's to release Q4 and full year FY26 results on Tuesday, May 12th, 2026; Earnings call slated @19:30 PM IST / 10:00 AM ET”

This is for your information and records.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

DR. REDDY'S LABORATORIES LTD.

8-2-337, Road No. 3, Banjara Hills,

Hyderabad – 500034, Telangana, India.

CONTACT

Investor relationS

Media relationS

Aishwarya sitharam

aishwaryasitharam@drreddys.com

PRIYA K

priyak@drreddys.com

Dr. Reddy's to release Q4 and full year FY26 results on Tuesday, May 12^th, 2026;

Earnings call slated @19:30 PM IST / 10:00 AM ET

Hyderabad, India, April 24^th, 2026

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) will announce results for the quarter and year ended March 31^st, 2026 on Tuesday, May 12^th, 2026 after the Board Meeting.

Summary of Events

Event	Date and Time	Medium
Release of financial results	Tuesday, May 12^th, 2026, after the Board Meeting	Stock Exchange, Media, Company Website, Email
Press Meet Presentation	Will be available on the Company’s Website	Stock Exchange, Company’s Website www.drreddys.com
Earnings Call	Tuesday, May 12^th, 2026 at 19:30 PM IST / 10:00 AM ET	Hosted by the Company (Details below)
Audio as well as Transcript of the Earnings call	Will be available on the Company’s Website	Stock Exchange, Company’s Website www.drreddys.com

Earnings Call

Following the release, the management of the Company will host its earnings call to discuss the Company’s financial performance.

Pre-register with the link below:

https://drreddys.zoom.us/webinar/register/WN_DW56_eZ6SAGF8FWL6wa-EQ

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

1 document

Press Releases

EX-99.1 EXHIBIT 99.1 50.5 KB